Open Access

Curcumin enhances temsirolimus-induced apoptosis in human renal carcinoma cells through upregulation of YAP/p53

  • Authors:
    • Shan Xu
    • Zheng Yang
    • Yizeng Fan
    • Bing Guan
    • Jing Jia
    • Yang Gao
    • Ke Wang
    • Kaijie Wu
    • Xinyang Wang
    • Pengsheng Zheng
    • Dalin He
    • Peng Guo
  • View Affiliations

  • Published online on: November 10, 2016     https://doi.org/10.3892/ol.2016.5376
  • Pages: 4999-5006
  • Copyright: © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Curcumin has frequently been used as a therapeutic agent in the treatment of various types of disease and is known to enhance the drug sensitivity of cells. In the present study, the combined effect of curcumin and temsirolimus treatment on apoptosis in human renal cell carcinoma (RCC) cells was investigated. Temsirolimus is an inhibitor of the mechanistic target of rapamycin signaling pathway and used in the first‑line treatment of metastatic RCC. It was demonstrated that curcumin combined with temsirolimus markedly induced apoptosis in RCC cells, however this effect was not observed following curcumin or temsirolimus treatment alone. Co‑treatment with temsirolimus and curcumin led to the activation of cleaved poly ADP‑ribose polymerase and caspase 3, upregulation of p53 expression and nuclear translocation, and downregulation of B‑cell lymphoma 2 protein expression. Furthermore, curcumin treatment was demonstrated to increase Yes‑associated protein (YAP) expression in a time‑dependent manner, which was concurrent with the curcumin‑induced expression pattern of p53 after 2 h. In addition, knockdown of YAP by small interfering RNA caused the attenuation of curcumin‑induced increased p53 expression in RCC cells. In conclusion, the present results indicate that combined curcumin and temsirolimus treatment has a synergistic effect on apoptosis in human RCC cells, through the activation of p53. Mechanistically, YAP is essential in the induction of p53 expression by curcumin. Furthermore, the results suggest that pre‑treatment or co‑treatment of cells with low concentration curcumin enhances the response to targeted drugs, and this presents a potentially novel and efficient strategy to overcome drug resistance in human RCC.
View Figures
View References

Related Articles

Journal Cover

December-2016
Volume 12 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Xu S, Yang Z, Fan Y, Guan B, Jia J, Gao Y, Wang K, Wu K, Wang X, Zheng P, Zheng P, et al: Curcumin enhances temsirolimus-induced apoptosis in human renal carcinoma cells through upregulation of YAP/p53. Oncol Lett 12: 4999-5006, 2016
APA
Xu, S., Yang, Z., Fan, Y., Guan, B., Jia, J., Gao, Y. ... Guo, P. (2016). Curcumin enhances temsirolimus-induced apoptosis in human renal carcinoma cells through upregulation of YAP/p53. Oncology Letters, 12, 4999-5006. https://doi.org/10.3892/ol.2016.5376
MLA
Xu, S., Yang, Z., Fan, Y., Guan, B., Jia, J., Gao, Y., Wang, K., Wu, K., Wang, X., Zheng, P., He, D., Guo, P."Curcumin enhances temsirolimus-induced apoptosis in human renal carcinoma cells through upregulation of YAP/p53". Oncology Letters 12.6 (2016): 4999-5006.
Chicago
Xu, S., Yang, Z., Fan, Y., Guan, B., Jia, J., Gao, Y., Wang, K., Wu, K., Wang, X., Zheng, P., He, D., Guo, P."Curcumin enhances temsirolimus-induced apoptosis in human renal carcinoma cells through upregulation of YAP/p53". Oncology Letters 12, no. 6 (2016): 4999-5006. https://doi.org/10.3892/ol.2016.5376